The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
30th Jul 201510:47 amRNSPT Astra 2015 First Half Financial Statements
30th Jul 201510:07 amRNSHalf Yearly Results - 6 months ended 30 June 2015
30th Jul 201510:07 amRNSHalf Yearly Results - 6 months ended 30 June 2015
28th Jul 201510:32 amRNSFirst Half 2015 Results of PT Hero
2nd Jul 201510:08 amRNSNotice of 2015 Half-Yearly Results
18th Jun 20151:05 pmRNSJC&C Announces a US$772 Million Rights Issue
29th May 201510:27 amRNSTotal Voting Rights
22nd May 20157:00 amRNSMandarin Oriental JV to Acquire Hotel Ritz, Madrid
13th May 201510:40 amRNSDirector/PDMR Shareholding
8th May 201510:18 amRNSAdditional Listing
7th May 20153:48 pmRNSNon-Routine Resolutions submitted via NSM
7th May 20153:43 pmRNSResult of AGM
29th Apr 201510:58 amRNSJC&C 2015 First Quarter Financial Statements
29th Apr 201510:34 amRNSDividend
28th Apr 201512:31 pmRNSFirst Quarter 2015 Results
27th Apr 201511:06 amRNSPT Astra - 2015 First Quarter Financial Statements
27th Apr 201510:20 amRNSDividend
9th Apr 201512:43 pmRNSDirector/PDMR Shareholding
9th Apr 201510:26 amRNSAnnual Financial Report
7th Apr 20155:01 pmRNSResults of 1 for 4 Rights Issue
7th Apr 201510:11 amRNSDairy Farm Completes Inv in Yonghui Superstores
2nd Apr 201511:04 amRNSJC&C's Investment in Siam City Cement
1st Apr 201510:39 amRNSCirc re. Scrip Dividend Scheme
30th Mar 201510:39 amRNSDirector Declaration
30th Mar 20159:57 amRNSJC&C's Investment in Siam City Cement
16th Mar 20158:29 amRNSAdmission to Trading
13th Mar 201510:06 amRNSDairy Farm's Inv in Yonghui Receives Reg Approval
12th Mar 20159:42 amRNSPublication of Prospectus
5th Mar 20159:33 amRNS2014 Preliminary Announcement of Results
5th Mar 20159:32 amRNS2014 Preliminary Announcement of Results
5th Mar 20159:20 amRNS1 FOR 4 RIGHTS ISSUE TO RAISE US$316 MILLION
5th Mar 20159:18 amRNSDirectorate Change and Declaration
5th Mar 20159:16 amRNS2014 Preliminary Announcement of Results
5th Mar 20159:16 amRNS2014 Preliminary Announcement of Results
5th Mar 20159:16 amRNS2014 Preliminary Announcement of Results
27th Feb 20159:51 amRNS2014 Year End Results of PT Hero
26th Feb 201510:03 amRNS2014 Financial Statements & Dividend Announcement
26th Feb 20159:50 amRNSPT Astra 2014 Full Year Financial Statements
2nd Feb 20159:19 amRNSNotice of 2014 Final Results
7th Nov 20149:13 amRNSAcquisition of a 49% interest in Rose Pharmacy
5th Nov 201410:13 amRNSInterim Management Statement
5th Nov 201410:10 amRNSInterim Management Statement
5th Nov 201410:08 amRNSInterim Management Statement
5th Nov 201410:07 amRNSInterim Management Statement
5th Nov 201410:06 amRNSInterim Management Statement
4th Nov 201410:05 amRNSJC&C 2014 Third Quarter Financial Statements
31st Oct 20149:17 amRNSTotal Voting Rights
30th Oct 20149:37 amRNSPT Astra 2014 Third Quarter Financial Statements
30th Oct 20149:16 amRNS2014 Nine Months Results of PT Hero
15th Oct 201411:34 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.